cyproterone acetate has been researched along with goserelin in 44 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (15.91) | 18.7374 |
| 1990's | 19 (43.18) | 18.2507 |
| 2000's | 14 (31.82) | 29.6817 |
| 2010's | 4 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schmeller, N | 1 |
| Schulze, H; Senge, T | 1 |
| D'Eramo, G; Di Silverio, F; Sciarra, F | 1 |
| Moffat, LE | 1 |
| D'Eramo, G; Di Silverio, F; Sciarra, F; Serio, M | 1 |
| de Jong, FH; Lamberts, SW; Uitterlinden, P | 1 |
| Bolton, C; Gingell, JC; Hartog, M; Kadow, C; Paisey, RB | 1 |
| Claes, HI; Vandenbussche, L; Vereecken, RL | 1 |
| Hjertberg, H; Kågedal, B; Nordenskjöld, B; Svensson, M; Varenhorst, E | 1 |
| Bouffioux, C | 1 |
| Allen, JM; Bloom, SR; Kerle, D; O'Shea, JP; Smith, C; Williams, G; Yeo, T | 1 |
| Akakura, K; Bruchovsky, N; Gleave, ME; Goldenberg, SL; Sullivan, LD | 1 |
| Gillatt, D; Peters, TJ; Reynard, JM | 1 |
| Akakura, K; Bruchovsky, N; Buckley, AR; Goldenberg, SL; Rennie, PS; Sullivan, LD | 1 |
| Akakura, K; Bruchovsky, N; Goldenberg, SL; Rennie, PS | 1 |
| Chisholm, GD; Love, C; Paul, AB | 1 |
| Heathcote, PS; Kateley, GD; Lloyd, S; Nicol, DL | 1 |
| Bolton, CH; Chadwick, D; Downs, LG; Gillatt, DA; Gingell, JC; Hopton, MI | 1 |
| Acar, O; Goldschmidt, AJ; Tunn, UW | 1 |
| Crosignani, PG; Falsetti, L; Maggioni, P; Motta, T; Testa, G; Vegetti, W | 1 |
| Azmatullah, S; Fellows, GJ; Gingell, JC; O'Boyle, PJ; Thorpe, SC | 1 |
| Andert, S; Dürer, A; Haberl, I; Hamilton, G; Holub, S; Theyer, G; Theyer, U | 1 |
| Bernier, J; Bolla, M; Collette, L; Dubois, JB; Gil, T; Gonzalez, D; Kuten, A; Mirimanoff, RO; Pierart, M; Sternberg, C; Storme, G; Warde, P | 1 |
| de Voogt, H; Denis, L; Sylvester, RJ | 1 |
| Dahlgren, E; Holm, G; Janson, PO; Krotkiewski, M; Landin, K | 2 |
| A'Hern, R; Hardy, J; Huddart, R; Richards, M; Stone, P | 1 |
| Dearnaley, DP; Gapinski, CJ; Husband, JE; Leach, MO; MacVicar, AD; Padhani, AR; Parker, GJ; Suckling, J | 1 |
| de Matteis, A; Di Paolo, B; Franco, G; Guidi, A; Revoltella, RP | 1 |
| Collette, L; Denis, LJ; Schröder, FH; Studer, UE; Sylvester, RJ | 1 |
| Dearnaley, DP; Horwich, A; Huddart, RA; Norman, AR; Parker, CC | 1 |
| Gardiner, RA; Green, HJ; Headley, BC; Mactaggart, PN; Nicol, DL; Pakenham, KI; Swanson, C; Watson, RB; Yaxley, J | 1 |
| Gardiner, RA; Green, HJ; Headley, BC; Mactaggart, PN; Nicol, DL; Pakenham, KI; Swanson, CE; Watson, RB; Yaxley, J | 1 |
| Collette, L; Debois, M; Fosså, SD; Hoekstra, W; Karthaus, PP; Kurth, KH; Schröder, FH | 1 |
| Benney, M; Gillatt, DA; Okeke, AA; Sugiono, M; Winkler, MH | 1 |
| Bloomfield, DJ; Edginton, TL; Jenkins, VA; Shilling, VM | 1 |
| Costantini, A; Di Silverio, F; Serio, M | 1 |
| Cecchini, MG; Klima, I; Peternac, D; Studer, UE; Thalmann, GN | 1 |
| Aherne, NJ; Chong, VS; Shakespeare, TP; Steer, AN | 1 |
| Bernier, J; Billiet, I; Bolla, M; Collette, L; Cutajar, CL; Dubois, JB; Kuten, A; Mirimanoff, RO; Pfeffer, R; Sternberg, C; Storme, G; Torecilla, JL; Van der Kwast, T; Van Tienhoven, G; Warde, P | 1 |
| D'Amico, AV | 1 |
| Bagatini, MD; Battisti, IE; Battisti, V; Chiesa, J; Duarte, MM; Gonçalves, JF; Maders, LD; Morsch, VM; Reetz, LG; Schetinger, MR | 1 |
| Assumpção, AA; Bradford, JM; Garcia, FD; Garcia, HD; Thibaut, F | 1 |
1 review(s) available for cyproterone acetate and goserelin
| Article | Year |
|---|---|
Pharmacologic treatment of paraphilias.
Topics: Androgen Antagonists; Antidepressive Agents; Cyproterone Acetate; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Medroxyprogesterone Acetate; Paraphilic Disorders; Selective Serotonin Reuptake Inhibitors; Triptorelin Pamoate | 2014 |
20 trial(s) available for cyproterone acetate and goserelin
| Article | Year |
|---|---|
Advanced prostatic cancer: clinical and hormonal response to flutamide in patients pretreated with LHRH analogue and cyproterone acetate.
Topics: Aged; Androgen Antagonists; Anilides; Buserelin; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Flutamide; Goserelin; Humans; Male; Middle Aged; Prostatic Neoplasms; Random Allocation | 1990 |
Comparison of Zoladex, diethylstilbestrol and cyproterone acetate treatment in advanced prostate cancer.
Topics: Androgen Antagonists; Breast; Buserelin; Cardiovascular Diseases; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Goserelin; Humans; Male; Prospective Studies; Prostatic Neoplasms | 1990 |
Zoladex vs. Zoladex plus cyproterone acetate in the treatment of advanced prostatic cancer: a multicenter Italian study.
Topics: Acid Phosphatase; Aged; Androgen Antagonists; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Buserelin; Cyproterone; Cyproterone Acetate; Follow-Up Studies; Gonadotropin-Releasing Hormone; Goserelin; Humans; Male; Prostatic Neoplasms; Testosterone | 1990 |
Total androgen blockade in advanced prostatic cancer. Critical review and personal experience.
Topics: Androgen Antagonists; Buserelin; Cyproterone; Cyproterone Acetate; Flutamide; Goserelin; Humans; Male; Multicenter Studies as Topic; Orchiectomy; Prostatic Neoplasms; Time Factors | 1988 |
Intermittent androgen suppression in the treatment of prostate cancer: a preliminary report.
Topics: Aged; Aged, 80 and over; Androgen Antagonists; Cyproterone Acetate; Diethylstilbestrol; Drug Therapy, Combination; Follow-Up Studies; Goserelin; Humans; Leuprolide; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Staging; Neoplasms, Hormone-Dependent; Prostate-Specific Antigen; Prostatic Neoplasms; Survival Rate; Time Factors | 1995 |
Luteinizing hormone-releasing hormone agonists in prostate cancer. Elimination of flare reaction by pretreatment with cyproterone acetate and low-dose diethylstilbestrol.
Topics: Acid Phosphatase; Adult; Aged; Aged, 80 and over; Cyproterone Acetate; Diethylstilbestrol; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Goserelin; Humans; Luteinizing Hormone; Male; Middle Aged; Neoplasm Staging; Pilot Projects; Pituitary Gland; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Remission Induction; Survival Rate; Testosterone | 1993 |
Effects of androgen deprivation prior to radical prostatectomy in 375 patients.
Topics: Androgen Antagonists; Antineoplastic Agents, Hormonal; Combined Modality Therapy; Cyproterone Acetate; Flutamide; Gonadotropin-Releasing Hormone; Goserelin; Humans; Leuprolide; Male; Middle Aged; Neoplasm Staging; Prostate; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Time Factors | 1996 |
An open randomized comparative study of an oral contraceptive containing ethinyl estradiol and cyproterone acetate with and without the GnRH analogue goserelin in the long-term treatment of hirsutism.
Topics: Acne Vulgaris; Adult; Contraceptives, Oral; Cyproterone Acetate; Estradiol; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Goserelin; Hirsutism; Humans; Luteinizing Hormone; Testosterone | 1996 |
A prospective, randomised study to compare goserelin acetate (Zoladex) versus cyproterone acetate (Cyprostat) versus a combination of the two in the treatment of metastatic prostatic carcinoma.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Cyproterone Acetate; Disease Progression; Goserelin; Humans; Male; Middle Aged; Prospective Studies; Prostatic Neoplasms; Safety | 1996 |
Measurements of tissue polypeptide-specific antigen and prostate-specific antigen in prostate cancer patients under intermittent androgen suppression therapy.
Topics: Adenocarcinoma; Androgen Antagonists; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Cyproterone Acetate; Drug Administration Schedule; Goserelin; Humans; Male; Prostate-Specific Antigen; Prostatic Neoplasms; Testosterone; Tissue Polypeptide Antigen | 1997 |
Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin.
Topics: Adenocarcinoma; Aged; Androgen Antagonists; Antineoplastic Agents, Hormonal; Chemotherapy, Adjuvant; Cyproterone Acetate; Goserelin; Humans; Male; Middle Aged; Neoplasm Staging; Prostatic Neoplasms; Survival Analysis; Treatment Outcome | 1997 |
The importance of prognostic factors in the interpretation of two EORTC metastatic prostate cancer trials. European Organization for Research and Treatment of Cancer (EORTC) Genito-Urinary Tract Cancer Cooperative Group.
Topics: Aged; Analysis of Variance; Androgen Antagonists; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Buserelin; Combined Modality Therapy; Cyproterone Acetate; Disease-Free Survival; Flutamide; Goserelin; Humans; Liver Neoplasms; Lung Neoplasms; Male; Middle Aged; Multivariate Analysis; Neoplasm Staging; Orchiectomy; Prognosis; Proportional Hazards Models; Prostatic Neoplasms; Risk Assessment; Survival Rate | 1998 |
Effects of two antiandrogen treatments on hirsutism and insulin sensitivity in women with polycystic ovary syndrome.
Topics: Adult; Androgen Antagonists; Androgens; Cyproterone Acetate; Estradiol Congeners; Ethinyl Estradiol; Female; Goserelin; Hirsutism; Humans; Insulin Resistance; Lipids; Polycystic Ovary Syndrome | 1998 |
Pre-treatment nomogram for biochemical control after neoadjuvant androgen deprivation and radical radiotherapy for clinically localised prostate cancer.
Topics: Administration, Oral; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Agents, Hormonal; Combined Modality Therapy; Cyproterone Acetate; Goserelin; Humans; Leuprolide; Male; Middle Aged; Neoadjuvant Therapy; Patient Care Planning; Predictive Value of Tests; Prognosis; Prostate-Specific Antigen; Prostatic Neoplasms; Retrospective Studies; Treatment Outcome | 2002 |
Altered cognitive function in men treated for prostate cancer with luteinizing hormone-releasing hormone analogues and cyproterone acetate: a randomized controlled trial.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Androgen Antagonists; Antineoplastic Agents, Hormonal; Cognition Disorders; Cyproterone Acetate; Drug Combinations; Goserelin; Humans; Leuprolide; Male; Middle Aged; Prostatic Neoplasms | 2002 |
Quality of life compared during pharmacological treatments and clinical monitoring for non-localized prostate cancer: a randomized controlled trial.
Topics: Aged; Androgen Antagonists; Antineoplastic Agents, Hormonal; Cognition Disorders; Cyproterone Acetate; Goserelin; Humans; Leuprolide; Male; Prostatic Neoplasms; Quality of Life; Sexual Dysfunction, Physiological; Stress, Psychological | 2004 |
Early versus delayed endocrine treatment of pN1-3 M0 prostate cancer without local treatment of the primary tumor: results of European Organisation for the Research and Treatment of Cancer 30846--a phase III study.
Topics: Adult; Aged; Androgen Antagonists; Antineoplastic Agents, Hormonal; Cyproterone Acetate; Drug Therapy, Combination; Follow-Up Studies; Goserelin; Humans; Lymphatic Metastasis; Male; Middle Aged; Prostatic Neoplasms; Survival Rate; Time Factors | 2004 |
Bicalutamide vs cyproterone acetate in preventing flare with LHRH analogue therapy for prostate cancer--a pilot study.
Topics: Aged; Androgen Antagonists; Anilides; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Cyproterone Acetate; Goserelin; Humans; Injections, Subcutaneous; Male; Nitriles; Pain; Prostatic Neoplasms; Tosyl Compounds | 2005 |
Does neoadjuvant hormone therapy for early prostate cancer affect cognition? Results from a pilot study.
Topics: Aged; Androgen Antagonists; Antineoplastic Agents, Hormonal; Cognition Disorders; Cyproterone Acetate; Goserelin; Humans; Intelligence; Male; Memory Disorders; Middle Aged; Neoadjuvant Therapy; Pilot Projects; Prostatic Neoplasms; Quality of Life; Speech Disorders; Surveys and Questionnaires | 2005 |
External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study.
Topics: Adenocarcinoma; Androgen Antagonists; Antineoplastic Combined Chemotherapy Protocols; Canada; Cardiovascular Diseases; Chemotherapy, Adjuvant; Cyproterone Acetate; Disease-Free Survival; Dose Fractionation, Radiation; Drug Administration Schedule; Europe; Fractures, Bone; Goserelin; Humans; Israel; Kaplan-Meier Estimate; Lymphatic Metastasis; Male; Neoplasm Invasiveness; Neoplasm Staging; Prostatic Neoplasms; Risk Assessment; Russia; Time Factors; Treatment Outcome | 2010 |
23 other study(ies) available for cyproterone acetate and goserelin
| Article | Year |
|---|---|
[A 79-year-old man with metastatic prostate cancer, treated with Zoladex, flutamide, calcitonin and Ostac, suffers from frequent troublesome sweating with palpitation and angina pectoris, especially at night. Is there a therapy?].
Topics: Aged; Androgen Antagonists; Angina Pectoris; Buserelin; Calcitonin; Cyproterone; Cyproterone Acetate; Flutamide; Goserelin; Humans; Hyperhidrosis; Male; Prostatic Neoplasms | 1992 |
Influence of different types of antiandrogens on luteinizing hormone-releasing hormone analogue-induced testosterone surge in patients with metastatic carcinoma of the prostate.
Topics: Acid Phosphatase; Aged; Androgen Antagonists; Buserelin; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Flutamide; Goserelin; Humans; Luteinizing Hormone; Male; Premedication; Prostatic Neoplasms; Testosterone; Time Factors | 1990 |
Rat prostatic weight regression in reaction to ketoconazole, cyproterone acetate, and RU 23908 as adjuncts to a depot formulation of gonadotropin-releasing hormone analogue.
Topics: Adrenocorticotropic Hormone; Animals; Buserelin; Cyproterone; Cyproterone Acetate; Delayed-Action Preparations; Goserelin; Imidazoles; Imidazolidines; Ketoconazole; Luteinizing Hormone; Male; Orchiectomy; Organ Size; Prostate; Prostatic Neoplasms; Rats; Rats, Inbred Strains | 1988 |
Effects of cyproterone acetate and a long-acting LHRH analogue on serum lipoproteins in patients with carcinoma of the prostate.
Topics: Buserelin; Cyproterone; Cyproterone Acetate; Goserelin; Humans; Lipoproteins; Lipoproteins, HDL; Lipoproteins, VLDL; Male; Prostatic Neoplasms; Urologic Diseases | 1986 |
Treatment of advanced carcinoma of the prostate by LHRH-agonists.
Topics: Buserelin; Cyproterone; Cyproterone Acetate; Goserelin; Humans; Male; Prostatic Neoplasms; Testosterone | 1987 |
Treatment of prostatic cancer by monthly injections of an LHRH-analogue depot.
Topics: Aged; Aged, 80 and over; Buserelin; Cyproterone; Cyproterone Acetate; Delayed-Action Preparations; Follicle Stimulating Hormone; Goserelin; Humans; Luteinizing Hormone; Male; Middle Aged; Prostatic Neoplasms; Testosterone | 1988 |
The effect of previous endocrine therapy on responses to a single dose of an LHRH analogue.
Topics: Adenocarcinoma; Buserelin; Castration; Cyproterone; Cyproterone Acetate; Diethylstilbestrol; Follicle Stimulating Hormone; Goserelin; Humans; Luteinizing Hormone; Male; Prostatic Neoplasms; Testosterone | 1984 |
Prostate-specific antigen and prognosis in patients with metastatic prostate cancer--a multivariable analysis of prostate cancer mortality.
Topics: Aged; Cyproterone Acetate; Goserelin; Humans; Male; Middle Aged; Multivariate Analysis; Prognosis; Prospective Studies; Prostate-Specific Antigen; Prostatic Neoplasms; Survival Rate | 1995 |
Effects of intermittent androgen suppression on androgen-dependent tumors. Apoptosis and serum prostate-specific antigen.
Topics: Adenocarcinoma; Aged; Animals; Apoptosis; Cyproterone Acetate; Diethylstilbestrol; Gonadotropin-Releasing Hormone; Goserelin; Humans; Male; Mammary Neoplasms, Experimental; Mice; Middle Aged; Neoplasm Staging; Neoplasm Transplantation; Neoplasms, Hormone-Dependent; Orchiectomy; Prostate-Specific Antigen; Prostatic Neoplasms; Testosterone | 1993 |
The management of bilateral ureteric obstruction and renal failure in advanced prostate cancer.
Topics: Cyproterone Acetate; Cystostomy; Goserelin; Humans; Kidney Failure, Chronic; Length of Stay; Male; Orchiectomy; Prognosis; Prospective Studies; Prostatic Neoplasms; Stents; Ureteral Obstruction; Ureterostomy | 1994 |
Advanced prostate cancer. The role of high priced hormone therapy.
Topics: Combined Modality Therapy; Cyproterone Acetate; Diagnosis-Related Groups; Drug Costs; Drug Therapy, Combination; Flutamide; Goserelin; Health Care Costs; Humans; Male; Orchiectomy; Prostatic Neoplasms; Queensland | 1993 |
Lipoprotein levels following treatment with cyproterone acetate or LHRH analogues.
Topics: Cholesterol; Cyproterone Acetate; Drug Therapy, Combination; Goserelin; Humans; Lipoproteins; Male; Prostatic Neoplasms; Triglycerides | 1993 |
Fatigue in patients with prostate cancer receiving hormone therapy.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyproterone Acetate; Fatigue; Female; Goserelin; Humans; Male; Middle Aged; Prostate-Specific Antigen; Prostatic Neoplasms; Quality of Life; Regression Analysis; Severity of Illness Index; Surveys and Questionnaires | 2000 |
Effects of androgen deprivation on prostatic morphology and vascular permeability evaluated with mr imaging.
Topics: Aged; Androgen Antagonists; Antineoplastic Agents, Hormonal; Biomarkers, Tumor; Capillary Permeability; Cyproterone Acetate; Drug Therapy, Combination; Goserelin; Humans; Magnetic Resonance Imaging; Male; Prospective Studies; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms | 2001 |
Endothelin-1 in human prostatic carcinoma treated with androgen withdrawal: an immunohistochemical study.
Topics: Aged; Antineoplastic Agents, Hormonal; Cyproterone Acetate; Endothelin-1; Goserelin; Humans; Immunoenzyme Techniques; Leuprolide; Male; Middle Aged; Prostatectomy; Prostatic Neoplasms; Receptors, Androgen; Treatment Outcome | 2001 |
Why phase III trials of maximal androgen blockade versus castration in M1 prostate cancer rarely show statistically significant differences.
Topics: Androgen Antagonists; Anilides; Clinical Trials, Phase III as Topic; Cyproterone Acetate; Factor Analysis, Statistical; Flutamide; Gonadotropin-Releasing Hormone; Goserelin; Humans; Imidazoles; Imidazolidines; Leuprolide; Male; Meta-Analysis as Topic; Nitriles; Orchiectomy; Prognosis; Prostatic Neoplasms; Research Design; Survival Analysis; Tosyl Compounds; Treatment Outcome | 2001 |
Improved prostate cancer treatment.
Topics: Androgen Antagonists; Combined Modality Therapy; Controlled Clinical Trials as Topic; Cyproterone Acetate; Goserelin; Humans; Male; Prostatic Neoplasms; United States | 2002 |
Effect of two modes of antiandrogen treatment on insulin sensitivity and serum leptin in women with PCOS.
Topics: Adipose Tissue; Adult; Androgen Antagonists; Apolipoproteins A; Apolipoproteins B; Blood Glucose; Body Composition; Body Constitution; Body Mass Index; Body Weight; C-Peptide; Cyproterone Acetate; Dehydroepiandrosterone Sulfate; Ethinyl Estradiol; Female; Gonadotropin-Releasing Hormone; Goserelin; Humans; Insulin; Insulin Resistance; Leptin; Lipoprotein(a); Obesity; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone; Triglycerides | 2003 |
Use of the LHRH analogue zoladex depot alone and in combination with cyproterone acetate in the treatment of advanced prostatic cancer.
Topics: Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Cyproterone Acetate; Disease Progression; Goserelin; Humans; Male; Neoplasm Staging; Prostatic Neoplasms; Survival Analysis; Treatment Outcome | 1989 |
Prostate specific antigen expression does not necessarily correlate with prostate cancer cell growth.
Topics: Androgen Antagonists; Anilides; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cyproterone Acetate; DNA, Complementary; Goserelin; Humans; Male; Nitriles; Polymerase Chain Reaction; Prostate-Specific Antigen; Prostatic Neoplasms; RNA, Messenger; Tosyl Compounds | 2006 |
Steroidal antiandrogen administration to treat gonadotropin-releasing hormone analogue-induced orchialgia.
Topics: Aged; Androgen Antagonists; Cyproterone Acetate; Gonadotropin-Releasing Hormone; Goserelin; Humans; Male; Pain; Steroids; Testicular Diseases; Testis | 2009 |
Is long-term androgen suppression right for everyone with locally advanced prostate cancer?
Topics: Adenocarcinoma; Androgen Antagonists; Antineoplastic Combined Chemotherapy Protocols; Cardiovascular Diseases; Chemotherapy, Adjuvant; Cyproterone Acetate; Disease-Free Survival; Dose Fractionation, Radiation; Drug Administration Schedule; Fractures, Bone; Goserelin; Humans; Lymphatic Metastasis; Male; Neoplasm Invasiveness; Neoplasm Staging; Patient Selection; Prostatic Neoplasms; Risk Assessment; Time Factors; Treatment Outcome | 2010 |
Oxidative stress and antioxidant status in prostate cancer patients: relation to Gleason score, treatment and bone metastasis.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Ascorbic Acid; Bone Neoplasms; Catalase; Cyproterone Acetate; Erythrocytes; Goserelin; Humans; Lipid Peroxidation; Male; Middle Aged; Neoplasm Grading; Oxidative Stress; Prostatic Neoplasms; Protein Carbonylation; Sulfhydryl Compounds; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Vitamin E | 2011 |